Strains of the bacteria Escherichia coli now account for more hospital-acquired infections than both MRSA and Clostridium difficile put together and are extremely difficult to treat with conventional antibiotics.
This latest research published in the Journal of Biological Chemistry has shed new light on how bacteria use ‘bacteriocins’, (substances that kill other strains of bacteria) to enter the bacterial cell and kill it, and how one bacteriocin produced by E. coli, ‘colicin A’, could be targeted to another cell protein (TolA) to create a new ‘Trojan horse’ weapon to ultimately kill the bacterial cell from within.
Bug on bug warfare
“Bacteriocins are receiving a lot of interest currently for their potential use in probiotics, cancer therapies, food security and new antimicrobial techniques. As current antibiotic treatments to fight superbugs are increasingly proving ineffective, it could be that harnessing the toxic power of bugs to fight rival bugs is going to be the way forward.
“Our research has specifically provided structural evidence that colicin A in E.coli binds to a novel binding site of the protein (TolA) which is present naturally and crucial to the health of a bacterial cell. This is significant because it could lead to potential antimicrobial therapies through the design of small novel synthetic compounds that could ultimately block the natural functions of TolA leading to cell death and the eradication of the infection.”
The researchers found that although colicins have good antimicrobial activity it is difficult to envisage using them as potential new antibiotics because they are large protein molecules that would activate the body’s immune response to provide protection on the next occasion the colicin is used for treatment.
How molecules penetrate cell defences
This new research into the physical interaction of colicins with components of a bacterial cell is vital to the understanding of how molecules can gain access and penetrate the defences of a bacterial cell. The research data shows that the interacting region of colicin A with TolA consists of a relatively small surface area whose bindingregion highlights essential molecular interactions that stabilise the interacting complex. This may provide important information for the design of novel synthetic substrates that could bind to and disable the essential functions of TolA leading to a loss of cellular functions associated with this protein and ultimately cell death.
Bacteria experts in conference at Nottingham
The E.coli ‘colicin A’ research will be one of the latest breakthroughs in this field of medical science under discussion at a Biochemical Society conference at The University of Nottingham in July. ‘How bugs kill bugs: progress and challenges in bacteriocin research’ will bring together experts in microbial ecology, cell biology, structural biology and molecular biophysics to explore the role played by bacteriocins in intermicrobial competition, the molecular mechanisms by which bacteriocins penetrate the formidable defences of bacteria and how bacteriocin import has yielded novel insights into the organization and structural biochemistry of the bacterial cell.
— Ends —
For up to the minute media alerts, follow us on Twitter at www.twitter.com/UoNPressOffice
Notes to editors: The University of Nottingham, described by The Sunday Times University Guide 2011 as ‘the embodiment of the modern international university’, has award-winning campuses in the United Kingdom, China and Malaysia. It is ranked in the UK’s Top 10 and the World’s Top 75 universities by the Shanghai Jiao Tong (SJTU) and the QS World University Rankings. It was named ‘the world’s greenest university’ in the UI GreenMetric World University Ranking 2011, a league table of the most environmentally-friendly higher education institutions.
The University is committed to providing a truly international education for its 40,000 students, producing world-leading research and benefiting the communities around its campuses in the UK and Asia. Impact: The Nottingham Campaign, its biggest ever fund-raising campaign, will deliver the University’s vision to change lives, tackle global issues and shape the future. For more details, visit: www.nottingham.ac.uk/impactcampaign
More than 90 per cent of research at The University of Nottingham is of international quality, according to the most recent Research Assessment Exercise, with almost 60 per cent of all research defined as ‘world-leading’ or ‘internationally excellent’. Research Fortnight analysis of RAE 2008 ranked the University 7th in the UK by research power.
The University’s vision is to be recognised around the world for its signature contributions, especially in global food security, energy & sustainability, and health. The University won a Queen’s Award for Higher and Further Education in 2011, for its research on global food security.
More news from the University at: www.nottingham.ac.uk/news
More information is available from Dr Christopher Penfold on +44 (0)115 84 67957 or [email protected]
Emma Rayner – Media Relations Manager
Email: [email protected] Phone: +44 (0)115 951 5793 Location: King’s Meadow Campus